[go: up one dir, main page]

AR031939A1 - Formulaciones de antibiotico de ionoforo - Google Patents

Formulaciones de antibiotico de ionoforo

Info

Publication number
AR031939A1
AR031939A1 ARP010105857A ARP010105857A AR031939A1 AR 031939 A1 AR031939 A1 AR 031939A1 AR P010105857 A ARP010105857 A AR P010105857A AR P010105857 A ARP010105857 A AR P010105857A AR 031939 A1 AR031939 A1 AR 031939A1
Authority
AR
Argentina
Prior art keywords
ionoforo
antibiotico
formulations
ionophore antibiotic
composition
Prior art date
Application number
ARP010105857A
Other languages
English (en)
Original Assignee
Eli Lilly & Company Nz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ509092A external-priority patent/NZ509092A/en
Application filed by Eli Lilly & Company Nz Ltd filed Critical Eli Lilly & Company Nz Ltd
Publication of AR031939A1 publication Critical patent/AR031939A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

La invencion se refiere a una composicion de antibiotico de ionoforo capaz de diluirse en agua hasta lograr una forma de dispersion sustancialmente estable en todo el agua presente, dicha composicion comprende o incluye: al menos un antibiotico de ionoforo (preferentemente monensin) de un tamano promedio de partícula de 20 micrones, - y al menos un agente de dispersion. También se divulga un método para preparar la composicion de un antibiotico ionoforo.
ARP010105857A 2000-12-19 2001-12-18 Formulaciones de antibiotico de ionoforo AR031939A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ509092A NZ509092A (en) 2000-12-19 2000-12-19 Ionophore antibiotic formulations containing a dispersing agent with the ionophore antibiotic having a mean particle size of less than 20 microns
NZ51418301 2001-09-13

Publications (1)

Publication Number Publication Date
AR031939A1 true AR031939A1 (es) 2003-10-08

Family

ID=26652236

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010105857A AR031939A1 (es) 2000-12-19 2001-12-18 Formulaciones de antibiotico de ionoforo

Country Status (12)

Country Link
US (2) US20040071782A1 (es)
EP (1) EP1345587B1 (es)
KR (1) KR20030078871A (es)
AR (1) AR031939A1 (es)
AT (1) ATE440591T1 (es)
AU (2) AU2002216503B9 (es)
BR (1) BRPI0116282B1 (es)
CA (1) CA2430791C (es)
DE (1) DE60139712D1 (es)
ES (1) ES2331406T3 (es)
MX (1) MXPA03005512A (es)
WO (1) WO2002049609A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2910323A1 (fr) * 2006-12-26 2008-06-27 Virbac Sa Sa Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
US9149456B2 (en) * 2008-07-28 2015-10-06 Zoetis Services Llc Laidlomycin compositions and methods
US8415121B2 (en) * 2009-10-05 2013-04-09 Alpharma, Llc Process for the manufacture of laidlomycin
EP3258920B1 (en) 2015-02-17 2023-03-29 Universiteit Gent Solid pharmaceutical dosage form suitable for use as drinking water medication
MX377257B (es) * 2015-04-28 2025-03-07 Elanco Us Inc Gránulos de monensina dispersables en agua por granulación húmeda.
KR102227147B1 (ko) * 2018-08-30 2021-03-12 한국화학연구원 이오노포어를 유효성분으로 포함하는 바이러스성 질환의 예방 또는 치료용 보조제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754856A (fr) 1969-08-18 1971-02-15 Hoffmann La Roche Nouveaux antibiotiques
US3829557A (en) 1970-06-12 1974-08-13 Erco Ind Ltd Production of chlorine dioxide
US3839557A (en) * 1972-01-24 1974-10-01 Lilly Co Eli Antibiotics monensin and a204 for improving ruminant feed efficiency
IL70015A0 (en) 1983-10-20 1984-01-31 Koffolk 1949 Ltd Ionophore antibiotic compositions and processes for the preparation thereof
US4746349A (en) * 1986-08-06 1988-05-24 American Cyanamid Company Method and compositions for suppressing the nitrification of ammonium in plant growth medium
NZ272574A (en) * 1995-07-14 1999-02-25 Lilly Eli & Co Nz Ltd Aqueous base suspension concentrate containing at least one ionophore antibiotic and wetting agent and/or a surfactant and xanthan gum optionally with a suspension agent, an antifreeze agent and an antifoaming agent; drench for veterinary treatment
DK0839024T3 (da) 1995-07-14 2004-08-16 Elli Lilly & Co Nz Ltd Ionofore antibiotiske formuleringer
US6086633A (en) * 1996-10-17 2000-07-11 Eli Lilly And Company Method for preserving animal hides
JP2001500900A (ja) * 1996-10-17 2001-01-23 イーライ・リリー・アンド・カンパニー 動物皮の保存方法
US6211185B1 (en) * 1999-05-05 2001-04-03 Veterinary Pharmacy Corporation Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent

Also Published As

Publication number Publication date
AU1650302A (en) 2002-07-01
ATE440591T1 (de) 2009-09-15
AU2002216503B9 (en) 2006-10-12
MXPA03005512A (es) 2004-10-14
AU2002216503B2 (en) 2006-04-27
CA2430791A1 (en) 2002-06-27
BRPI0116282B1 (pt) 2016-04-19
CA2430791C (en) 2010-02-02
EP1345587A1 (en) 2003-09-24
ES2331406T3 (es) 2010-01-04
US20090238881A1 (en) 2009-09-24
BR0116282A (pt) 2004-03-02
US20040071782A1 (en) 2004-04-15
EP1345587B1 (en) 2009-08-26
DE60139712D1 (de) 2009-10-08
WO2002049609A1 (en) 2002-06-27
KR20030078871A (ko) 2003-10-08

Similar Documents

Publication Publication Date Title
MXPA03009284A (es) Una formulacion reguladora del crecimiento de la planta granular, soluble en agua, concentrada y metodos para utilizar la misma.
CA2338703A1 (en) Injectable aqueous dispersions of propofol
MY127266A (en) Aqueous dispersion, a process for the preparation and the use thereof
CA2400317A1 (en) Improved paste formulations
BR0109091A (pt) Formulações de ranolazina de liberação sustentada
AR011611A1 (es) Composiciones en gel postespumante
AU7119500A (en) Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
EP0587744A4 (en) Chewable drug-delivery composition
AU2001238539A1 (en) Improved methods for dispersing fibers within aqueous compositions
PE20020968A1 (es) Preparados de insulina exentos de zinc y pobres en zinc, con estabilidad mejorada
HK1080358A1 (zh) 包含增厚聚合物和阳离子表面活性剂的护发组合物
DK0830145T3 (da) Formuleringer omfattende leflunomid
BR0115952A (pt) Composição de emulsão para administração terapêutica, método de administração, processo para o preparo de uma formulação contendo derivados de fosfato de agentes de transferência de elétrons
AR031939A1 (es) Formulaciones de antibiotico de ionoforo
AU2001235783A1 (en) Therapeutic compositions for pulmonary delivery
PT961855E (pt) Dispersoes aquosas de um agente de colagem hidrofobo
WO2002032425A3 (en) Stable oral formulation containing benzimidazole derivative
ES2231176T3 (es) Uso de beta-(1,3)-glucanos nanometricos hidrosolubles.
AR007178A1 (es) Formulacion que contiene microparticulas, para la inhalacion
ES2039621T3 (es) Agente de limpieza abrasivo acuoso espesado que no exhibe sineresis y metodo para su preparacion.
ES2060293T3 (es) Nueva sustancia antiulcerosa.
ATE273353T1 (de) Metalloxiddispersion
BR0009855A (pt) Composição de cuidado oral, e, uso de um metal alcalino, amÈnio ou alquilsulfato c10 de amÈnio substituìdo
AU2001270310A1 (en) Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same
IT1317861B1 (it) Uso di composti fluorurati per conferire proprieta' release.

Legal Events

Date Code Title Description
FC Refusal